Preoperative Chemotherapy Does Not Adversely Affect Pancreatic Structure and Short-Term Outcome after Pancreatectomy

[1]  M. Braga,et al.  Effect of Surgeon Volume on Outcome Following Pancreaticoduodenectomy in a High-Volume Hospital , 2012, Journal of Gastrointestinal Surgery.

[2]  G. Kayser,et al.  A simple scoring system based on clinical factors related to pancreatic texture predicts postoperative pancreatic fistula preoperatively. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[3]  Tibor Schuster,et al.  Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages , 2010, PLoS medicine.

[4]  Jeffrey E. Lee,et al.  Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation , 2010, Annals of Surgical Oncology.

[5]  M. Reni,et al.  Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma , 2009, Cancer Chemotherapy and Pharmacology.

[6]  M. Schäfer,et al.  Neoadjuvant Chemotherapy Generates a Significant Tumor Response in Resectable Pancreatic Cancer Without Increasing Morbidity: Results of a Prospective Phase II Trial , 2008, Annals of surgery.

[7]  M. Braga,et al.  Fast‐track recovery programme after pancreatico‐ duodenectomy reduces delayed gastric emptying , 2008, The British journal of surgery.

[8]  Jeffrey E. Lee,et al.  Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. , 2008, Journal of the American College of Surgeons.

[9]  G. Balzano,et al.  Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy , 2008, The British journal of surgery.

[10]  K. Lillemoe,et al.  Fatty Pancreas: A Factor in Postoperative Pancreatic Fistula , 2007, Annals of surgery.

[11]  D. Stocken,et al.  A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin , 2007, Annals of Surgical Oncology.

[12]  J. Cameron,et al.  Assessment of Complications After Pancreatic Surgery: A Novel Grading System Applied to 633 Patients Undergoing Pancreaticoduodenectomy , 2006, Annals of surgery.

[13]  Jeffrey E. Lee,et al.  Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy , 2006, Annals of Surgical Oncology.

[14]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[15]  J. Cameron,et al.  One Thousand Consecutive Pancreaticoduodenectomies , 2006, Annals of surgery.

[16]  B. Nordlinger,et al.  Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver Metastases , 2006, Annals of surgery.

[17]  A. K. Chan,et al.  Neoadjuvant Chemoradiation Increases the Risk of Pelvic Sepsis After Radical Excision of Rectal Cancer , 2005, Diseases of the colon and rectum.

[18]  J. Neoptolemos,et al.  Postoperative pancreatic fistula: an international study group (ISGPF) definition. , 2005, Surgery.

[19]  H. Friess,et al.  Randomized clinical trial of pylorus‐preserving duodenopancreatectomy versus classical Whipple resection—long term results , 2005, The British journal of surgery.

[20]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[21]  Douglas B. Evans,et al.  Neoadjuvant therapy for resectable pancreatic cancer. , 2004, Surgical oncology clinics of North America.

[22]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[23]  Helen Hickey,et al.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. , 2004, The New England journal of medicine.

[24]  M. Braga,et al.  Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial , 2001, The Lancet.

[25]  P J Kumar,et al.  The Exocrine Pancreas. , 1980 .

[26]  A. Krasinskas,et al.  Assessing treatment effect in pancreatic cancer. , 2012, Archives of pathology & laboratory medicine.

[27]  T. Eberlein.  Postoperative Morbidity with Diversion after Low Anterior Resection in the Era of Neoadjuvant Therapy: A Single Institution Experience , 2010 .

[28]  T. Eberlein.  Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial , 2008 .

[29]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.